VC
AZN icon

Veracity Capital’s AstraZeneca AZN Stock Holding History

Veracity Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+1,623
New +$305K 0.08% 181
2026
Q1 		– Sell
-1,752
Closed -$322K – 207
2025
Q4 		$322K Buy
1,752
+20
+1% +$3.51K 0.09% 190
2025
Q3 		$266K Sell
1,732
-139
-7% -$21K 0.08% 208
2025
Q2 		$261K Sell
1,871
-149
-7% -$20.9K 0.09% 201
2025
Q1 		$297K Buy
2,020
+136
+7% +$19.7K 0.12% 173
2024
Q4 		$247K Sell
1,884
-33
-2% -$4.62K 0.09% 194
2024
Q3 		$299K Buy
1,917
+82
+4% +$13.2K 0.11% 163
2024
Q2 		$286K Sell
1,835
-152
-8% -$22.9K 0.12% 159
2024
Q1 		$269K Buy
1,987
+265
+15% +$35.1K 0.1% 178
2023
Q4 		$232K Sell
1,722
-53
-3% -$6.89K 0.09% 181
2023
Q3 		$240K Sell
1,775
-499
-22% -$68.2K 0.11% 167
2023
Q2 		$325K Sell
2,274
-32
-1% -$4.71K 0.14% 149
2023
Q1 		$320K Buy
2,306
+407
+21% +$54.8K 0.15% 149
2022
Q4 		$257K Buy
1,899
+45
+2% +$5.64K 0.12% 164
2022
Q3 		$203K Buy
+1,854
New +$235K 0.11% 168
2021
Q4 		– Sell
-2,261
Closed -$272K – 241
2021
Q3 		$272K Buy
+2,261
New +$263K 0.12% 193
2021
Q1 		– Sell
-4,154
Closed -$416K – 268
2020
Q4 		$416K Buy
4,154
+406
+11% +$43K 0.1% 201
2020
Q3 		$410K Buy
+3,748
New +$417K 0.11% 185
2020
Q2 		– Sell
-4,444
Closed -$397K – 235
2020
Q1 		$397K Sell
4,444
-333
-7% -$31.3K 0.11% 128
2019
Q4 		$476K Buy
+4,777
New +$450K 0.12% 129

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Veracity Capital's AZN Position: Q2 2026 in Review

Veracity Capital opened a new position in AstraZeneca (AZN) in Q2 2026: 1,623 shares worth $308K. The stake represents 0.08% of the portfolio and ranks #181 among its holdings. This is a return to the name: Veracity Capital previously reported a position in AZN as recently as Q4 2025.

Veracity Capital first reported a position in AZN in Q4 2019 and has held it in 20 quarters since. The position peaked at $476K in Q4 2019. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Veracity Capital held 1,623 shares of AstraZeneca worth $308K as of Q2 2026.
  • AstraZeneca was a new Veracity Capital position in Q2 2026.
  • AstraZeneca made up 0.08% of Veracity Capital's portfolio in Q2 2026, its #181 holding.
  • Veracity Capital first reported a position in AstraZeneca in Q4 2019 and has held it in 20 quarters since.
  • Veracity Capital's AstraZeneca position peaked at $476K in Q4 2019.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.